DXCM

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Dexcom Inc

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
CEO
Kevin Sayer
Employees
5500
Headquarters

6340 Sequence Dr
San Diego, California 92121-4356
Phone: 18582000200
www.dexcom.com

News

DexCom Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (DXCM) Investors with Significant Losses to Contact the Firm
Aug 08, 2024 23:08pm

Radnor, Pennsylvania--(Newsfile Corp. - August 8, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DexCom, Inc. (NASDAQ: DXCM) ("DexCom"). On July 25, 2024, after the market closed, DexCom announced disappointing earnings results for its second quarter of 2024 and Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
DXCM STOCK NOTICE: If You are a DexCom, Inc. Investor that Lost Money on Your Investment, Contact BFA Law about its Potential Class Action Lawsuit
Aug 08, 2024 19:33pm

New York, New York--(Newsfile Corp. - August 8, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into DexCom, Inc. (NASDAQ: DXCM) for potential violations of the federal securities laws. If you invested in DexCom, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/dexcom-inc. Why Did DexCom''s Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?
Aug 08, 2024 14:00pm

DexCom now trades at a drastically lower earnings multiple than it has in the past.


Source:The Motley Fool
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
Aug 08, 2024 13:29pm

On CNBC''s “Mad Money Lightning Round,” Jim Cramer said Oneok (NYSE: OKE ) is “terrific” and recommended buying more of the stock. On Aug. 5, ONEOK reported better-than-expected second-quarter GAAP EPS results, posting quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $1.21 per share. “The problem with Dollar Tree (NASDAQ: DLTR ) is that people I think have discovered that the small form is no longer working, they would rather go to Walmart (NYSE: WMT ), which is a buy, or Costco (NASDAQ: COST ) … Full story available on Benzinga.com


Source:Benzinga
DexCom''s Competitive Landscape: A Deep Dive Into The CGM Market
Aug 08, 2024 13:23pm

An analysis of DexCom, Inc.''s challenges and strengths, including competition from Abbott and market growth potential for its new device. Click for more on DXCM.


Source:Seeking Alpha
DXCM STOCK ALERT: Suffer Losses on Your DexCom, Inc. Securities? Contact BFA Law about its Investigation into NASDAQ:DXCM for Securities Fraud
Aug 08, 2024 10:16am

DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.


Source:GlobeNewswire
Lightning Round: Stay away from Dexcom, says Jim Cramer
Aug 07, 2024 23:53pm

''Mad Money'' host Jim Cramer weighs in on stock including: Dollar Tree, OneOk, Dexcom, CRISPR, and KeyCorp.


Source:CNBC
DexCom Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (DXCM) Investors with Significant Losses to Contact the Firm
Aug 07, 2024 20:11pm

Radnor, Pennsylvania--(Newsfile Corp. - August 7, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DexCom, Inc. (NASDAQ: DXCM) ("DexCom"). On July 25, 2024, after the market closed, DexCom announced disappointing earnings results for its second quarter of 2024 and Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
DexCom Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
Aug 07, 2024 13:15pm

RADNOR, Pa., Aug. 7, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DexCom, Inc. (NASDAQ: DXCM) ("DexCom"). On July 25, 2024, after the market…


Source:PR Newswire
DexCom Q2 Earnings: Traditional Market Overreaction
Aug 07, 2024 11:30am

DexCom''s lowered guidance reflects double-digit growth and profitability with DCF analysis suggesting 26% upside to current pricing. Find out why DXCM stock is a Buy.


Source:Seeking Alpha